Pasithea Therapeutics Corp. (KTTA): 3 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Dec 1, 2025 | Dumesnil Simon Director | 33,333 | $0.75 | $25.0K | no history |
| Dec 1, 2025 | Marques Tiago Director, Officer | 33,333 | $0.75 | $25.0K | no history |
| Dec 1, 2025 | Steinman Lawrence Director | 133,333 | $0.75 | $100.0K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.